pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

25,050 catalysts · 5,445 approval · 5,000 device 510k · 4,728 grant · 3,086 8k filing · 2,000 device pma · 2,000 device recall

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 57 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2023-02-08×clear all
type
  • approval5,445
  • device 510k5,000
  • grant4,728
  • 8k filing3,086
  • device pma2,000
  • device recall2,000
recall
1,126
  • device adverse event1,000
  • earnings583
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Mar 20, 2023

    9
    ›Mar 24, 2023approval1237d agoISOTRETINOIN — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 24, 2023approval1237d agoABSORICA (ISOTRETINOIN) — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: SUN PHARM INDS INC. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 24, 2023approval1237d agoAMNESTEEM (ISOTRETINOIN) — FDA approvalMylan Pharmaceuticals Inc

    Sponsor: MYLAN PHARMS INC. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 24, 2023approval1237d agoCLARAVIS (ISOTRETINOIN) — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 24, 2023approval1237d agoABSORICA LD (ISOTRETINOIN) — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: SUN PHARM. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 24, 2023approval1237d agoISOTRETINOIN — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 24, 2023approval1237d agoISOTRETINOIN — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: AMNEAL PHARMS NY. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 24, 2023approval1237d agoZENATANE (ISOTRETINOIN) — FDA approvalISOTRETINOIN

    Sponsor: DR REDDYS LABS LTD. Form: CAPSULE. Route: ORAL

    full page →ISOTRETINOIN →fda approvals ↗
    ›Mar 24, 2023approval1237d agoPREGABALIN — FDA approvalViatris Inc

    Sponsor: CHANGZHOU PHARM. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗

    Week of Mar 27, 2023

    14
    ›Mar 27, 2023approval1234d agoNARCAN (NALOXONE HYDROCHLORIDE) — FDA approvalEmergent Devices Inc

    Sponsor: EMERGENT. Form: SPRAY, METERED. Route: NASAL

    full page →fda approvals ↗
    ›Mar 27, 2023approval

    Week of Apr 3, 2023

    9
    ›Apr 3, 2023approval1227d agoKEYTRUDA (PEMBROLIZUMAB) — FDA approvalpembrolizumab

    Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

    full page →pembrolizumab →fda approvals ↗
    ›Apr 3, 2023approval

    Week of Apr 10, 2023

    7
    ›Apr 10, 2023approval1220d agoNISOLDIPINE — FDA approvalPrasco LLC

    Sponsor: AMTA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 10, 2023approval

    Week of Apr 17, 2023

    11
    ›Apr 17, 2023approval1213d agoVALACYCLOVIR HYDROCHLORIDE — FDA approvalVALACYCLOVIR HYDROCHLORIDE

    Sponsor: JUBILANT GENERICS. Form: TABLET. Route: ORAL

    full page →VALACYCLOVIR HYDROCHLORIDE →fda approvals ↗
    ›Apr 17, 2023approval
    ← prev
    page 3 of 501
    next →
    1234d ago
    HALOPERIDOL DECANOATE — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 27, 2023approval1234d agoBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalIGC Pharma, Inc.

    Sponsor: ALKEM LABS LTD. Form: TABLET. Route: SUBLINGUAL

    full page →fda approvals ↗
    ›Mar 28, 2023approval1233d agoKEYTRUDA (PEMBROLIZUMAB) — FDA approvalpembrolizumab

    Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

    full page →pembrolizumab →fda approvals ↗
    ›Mar 29, 2023approval1232d agoNARCAN (NALOXONE HYDROCHLORIDE) — FDA approvalEmergent Devices Inc

    Sponsor: EMERGENT. Form: SPRAY, METERED. Route: NASAL

    full page →fda approvals ↗
    ›Mar 29, 2023approval1232d agoVEKLURY (REMDESIVIR) — FDA approvalremdesivir

    Sponsor: GILEAD SCIENCES INC. Form: SOLUTION. Route: INTRAVENOUS

    full page →remdesivir →fda approvals ↗
    ›Mar 30, 2023approval1231d agoLINAGLIPTIN AND METFORMIN HYDROCHLORIDE (LINAGLIPTIN) — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 30, 2023approval1231d agoSIMPONI (GOLIMUMAB) — FDA approvalJanssen Biotech Inc

    Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 30, 2023approval1231d agoORGOVYX (RELUGOLIX) — FDA approvalrelugolix

    Sponsor: SUMITOMO PHARMA AM. Form: TABLET. Route: ORAL

    full page →relugolix →fda approvals ↗
    ›Mar 30, 2023approval1231d agoZIPRASIDONE HYDROCHLORIDE — FDA approvalLupin Ltd

    Sponsor: LUPIN PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 30, 2023approval1231d agoZIPRASIDONE HYDROCHLORIDE — FDA approvalLupin Ltd

    Sponsor: LUPIN PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 30, 2023approval1231d agoZIPRASIDONE HYDROCHLORIDE — FDA approvalLupin Ltd

    Sponsor: LUPIN PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 31, 2023approval1230d agoPREZCOBIX (COBICISTAT) — FDA approvalGILEAD SCIENCES, INC.

    Sponsor: JANSSEN PRODS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 31, 2023approval1230d agoYUSIMRY (ADALIMUMAB-AQVH) — FDA approvalYUSIMRY

    Sponsor: COHERUS BIOSCIENCES INC. Form: INJECTABLE. Route: INJECTION

    full page →YUSIMRY →fda approvals ↗
    1227d ago
    PADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approvalenfortumab vedotin

    Sponsor: ASTELLAS. Form: INJECTABLE. Route: INJECTION

    full page →enfortumab vedotin →fda approvals ↗
    ›Apr 3, 2023approval1227d agoPADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approvalenfortumab vedotin

    Sponsor: ASTELLAS. Form: INJECTABLE. Route: INJECTION

    full page →enfortumab vedotin →fda approvals ↗
    ›Apr 4, 2023approval1226d agoALEVE (NAPROXEN SODIUM) — FDA approvalNAPROXEN SODIUM

    Sponsor: BAYER. Form: TABLET. Route: ORAL

    full page →NAPROXEN SODIUM →fda approvals ↗
    ›Apr 4, 2023approval1226d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

    Sponsor: ZYDUS LIFESCIENCES. Form: TABLET. Route: ORAL

    full page →ACETAZOLAMIDE →fda approvals ↗
    ›Apr 4, 2023approval1226d agoNELARABINE — FDA approvalNELARABINE

    Sponsor: AMNEAL. Form: INJECTABLE. Route: INTRAVENOUS

    full page →NELARABINE →fda approvals ↗
    ›Apr 6, 2023approval1224d agoDILTIAZEM HYDROCHLORIDE — FDA approvalSciegen Pharmaceuticals Inc

    Sponsor: SCIEGEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 6, 2023approval1224d agoAMJEVITA (ADALIMUMAB-ATTO) — FDA approvalAMJEVITA

    Sponsor: AMGEN INC. Form: INJECTABLE. Route: INJECTION

    full page →AMJEVITA →fda approvals ↗
    ›Apr 7, 2023approval1223d agoATROPINE SULFATE — FDA approvalATROPINE SULFATE

    Sponsor: ACCORD HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS

    full page →ATROPINE SULFATE →fda approvals ↗
    1220d ago
    RINVOQ (UPADACITINIB) — FDA approvalupadacitinib tartrate ER

    Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →upadacitinib tartrate ER →fda approvals ↗
    ›Apr 13, 2023approval1217d agoCAPRELSA (VANDETANIB) — FDA approvalvandetanib

    Sponsor: GENZYME CORP. Form: TABLET. Route: ORAL

    full page →vandetanib →fda approvals ↗
    ›Apr 13, 2023approval1217d agoTEPEZZA (TEPROTUMUMAB-TRBW) — FDA approvalteprotumumab

    Sponsor: HORIZON THERAPEUTICS IRELAND. Form: INJECTABLE. Route: INJECTION

    full page →teprotumumab →fda approvals ↗
    ›Apr 14, 2023approval1216d agoRIZAFILM (RIZATRIPTAN BENZOATE) — FDA approvalNAL Pharmaceuticals Ltd

    Sponsor: GENSCO. Form: FILM. Route: ORAL

    full page →fda approvals ↗
    ›Apr 14, 2023approval1216d agoLUPRON DEPOT-PED KIT (LEUPROLIDE ACETATE) — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: ABBVIE ENDOCRINE INC. Form: POWDER. Route: INTRAMUSCULAR

    full page →fda approvals ↗
    ›Apr 14, 2023approval1216d agoHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalHYRIMOZ

    Sponsor: SANDOZ INC. Form: INJECTABLE. Route: INJECTION

    full page →HYRIMOZ →fda approvals ↗
    1213d ago
    VALACYCLOVIR HYDROCHLORIDE — FDA approvalVALACYCLOVIR HYDROCHLORIDE

    Sponsor: JUBILANT GENERICS. Form: TABLET. Route: ORAL

    full page →VALACYCLOVIR HYDROCHLORIDE →fda approvals ↗
    ›Apr 17, 2023approval1213d agoQULIPTA (ATOGEPANT) — FDA approvalatogepant

    Sponsor: ABBVIE. Form: TABLET. Route: ORAL

    full page →atogepant →fda approvals ↗
    ›Apr 18, 2023approval1212d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

    Sponsor: ALKEM. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 18, 2023approval1212d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

    Sponsor: ALKEM. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 18, 2023approval1212d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

    Sponsor: ALKEM. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 18, 2023approval1212d agoPADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approvalenfortumab vedotin

    Sponsor: ASTELLAS. Form: INJECTABLE. Route: INJECTION

    full page →enfortumab vedotin →fda approvals ↗
    ›Apr 19, 2023approval1211d agoPOLIVY (POLATUZUMAB VEDOTIN-PIIQ) — FDA approvalpolatuzumab vedotin

    Sponsor: GENENTECH. Form: POWDER. Route: INTRAVENOUS

    full page →polatuzumab vedotin →fda approvals ↗
    ›Apr 20, 2023approval1210d agoBOSULIF (BOSUTINIB MONOHYDRATE) — FDA approvalAlembic Pharmaceuticals Inc

    Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 20, 2023approval1210d agoSAXENDA (LIRAGLUTIDE) — FDA approvalNovo Nordisk Inc

    Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Apr 21, 2023approval1209d agoPEMETREXED DISODIUM — FDA approvalAlimta

    Sponsor: SANDOZ. Form: SOLUTION. Route: INTRAVENOUS

    full page →Alimta →fda approvals ↗
    $VTRS16.28-0.91%
    $RDY12.15-0.57%
    $AMRX17.47-2.29%
    $ABBV247.97+0.78%
    $ABBV247.97+0.78%
    $GILD133.06-0.11%
    $AMGN417.20+1.52%
    $AMRX17.47-2.29%
    $COGT41.53-2.03%
    $IGC0.2670+0.41%
    $GILD133.06-0.11%